LUMOS PHARMA INC - Common Stock (LUMO)

CUSIP: 55028X109

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Equity / Common Stock
Shares outstanding
8,122,625
Total 13F shares
2,360,021
Share change
-31,499
Total reported value
$8,575,404
Price per share
$3.61
Number of holders
35
Value change
-$534,037
Number of buys
15
Number of sells
10

Quarterly Holders Quick Answers

What is CUSIP 55028X109?
CUSIP 55028X109 identifies LUMO - LUMOS PHARMA INC - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of LUMOS PHARMA INC - Common Stock (LUMO) as of Q4 2022

As of 31 Dec 2022, LUMOS PHARMA INC - Common Stock (LUMO) was held by 35 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,360,021 shares. The largest 10 holders included GOLDMAN SACHS GROUP INC, Blackstone Inc., WELLS FARGO & COMPANY/MN, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, Jefferies Financial Group Inc., PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., Shay Capital LLC, and BRIDGEWAY CAPITAL MANAGEMENT, LLC. This page lists 35 institutional shareholders reporting positions in this security for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.